Head-to-head · Cost-Efficiency Index
OnlyRx vs PauseRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
OnlyRx
Shoppers who want a 50-state marketplace with multiple pharmacy options and named prescribers.
Visit OnlyRxPauseRX
Cost-first shoppers who want unconfirmed -- re-verify directly before recommending; site inaccessible to automated review.
Visit PauseRXThe verdict
OnlyRx and PauseRX tie on the Cost-Efficiency Index at 64/100, so neither wins outright on the numbers. For most shoppers we'd start with OnlyRx (ranked #180, a hair above #181) — Shoppers who want a 50-state marketplace with multiple pharmacy options and named prescribers. But PauseRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs OnlyRx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | OnlyRx | PauseRX |
|---|---|---|
| Cost-Efficiency Index | 64/100 | 64/100 |
| Semaglutide / mo | $179/mo (starting dose, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide / mo | $249/mo (starting dose, compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,148 | $2,388 |
| Tirzepatide / yr (modeled) | $2,988 | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Yes |
| Rank here | #180 | #181 |
OnlyRx
64/100Where the value is
- Serves all 50 states per its own claim, wider than most compounded-GLP-1 competitors
- Two named prescribers with published NPI numbers (Dr. Ana Lisa Carr, Dr. Kelly Tenbrink), plus two supporting providers
- Sources medication from four named, recognizable 503A-style pharmacy partners rather than one undisclosed source
The tradeoffs
- The $179 headline price is explicitly labeled a 'Summer Promo' on the site's own homepage — no post-promo price is published
- No dose-tier (mg) breakdown is published for any of the four price points
PauseRX
64/100Where the value is
- Cached snippet suggests a simple flat $199/month price regardless of dose
- Advertises 'no office visits' and delivery to your door
The tradeoffs
- Live site is blocked by persistent Cloudflare CAPTCHA -- could not be independently verified via direct fetch or proxy
- No medical director, pharmacy partner, states-served, or LegitScript status could be confirmed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.